These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
123 related items for PubMed ID: 18812659
1. [Effect of valsartan on postprandial plasma inflammatory factors in patients with essential hypertension]. Liu L, Zhao SP, Zhou HN, Xu DY, Li JX. Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 33(9):809-13. PubMed ID: 18812659 [Abstract] [Full Text] [Related]
2. Effect of fluvastatin and valsartan, alone and in combination, on postprandial vascular inflammation and fibrinolytic activity in patients with essential hypertension. Liu L, Zhao SP, Zhou HN, Li QZ, Li JX. J Cardiovasc Pharmacol; 2007 Jul; 50(1):50-5. PubMed ID: 17666915 [Abstract] [Full Text] [Related]
3. Postprandial hypertriglyceridemia associated with inflammatory response and procoagulant state after a high-fat meal in hypertensive patients. Liu L, Zhao SP, Wen T, Zhou HN, Hu M, Li JX. Coron Artery Dis; 2008 May; 19(3):145-51. PubMed ID: 18418230 [Abstract] [Full Text] [Related]
4. Fluvastatin blunts the effect of a high-fat meal on plasma triglyceride and high-sensitivity C-reactive protein concentrations in patients at high risk for cardiovascular events. Liu L, Zhao SP, Hu M, Li JX. Coron Artery Dis; 2007 Sep; 18(6):489-93. PubMed ID: 17700222 [Abstract] [Full Text] [Related]
5. Effects of valsartan and indapamide on plasma cytokines in essential hypertension. Xie QY, Wang YJ, Sun ZL, Yang TL. Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 31(5):629-34. PubMed ID: 17062919 [Abstract] [Full Text] [Related]
6. Effect of valsartan compared with valsartan/hydrochlorothiazide on plasma levels of cellular adhesion molecules: the Val-MARC trial. Conen D, Everett BM, Glynn RJ, Ridker PM. Heart; 2008 Mar; 94(3):e13. PubMed ID: 17923463 [Abstract] [Full Text] [Related]
7. Coadministration of valsartan 160 and 320 mg and simvastatin 20 and 40 mg in patients with hypertension and hypercholesterolemia: a multicenter, 12-week, double-blind, double-dummy, parallel-group superiority study. Rump LC, Baranova E, Okopien B, Weisskopf M, Kandra A, Ferber P. Clin Ther; 2008 Oct; 30(10):1782-93. PubMed ID: 19014834 [Abstract] [Full Text] [Related]
8. [The relationship between the gene polymorphism of TGF-beta1 and early renal injury in patients with essential hypertension, and the effect of the gene polymorphism of TGF- beta1 on the individual treatment with valsartan]. Zhao C, Wang YY, Xiao ZX, Wang YP, Zhang QY. Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Aug; 24(4):428-31. PubMed ID: 17680535 [Abstract] [Full Text] [Related]
9. Impact of supportive measures on drug adherence in patients with essential hypertension treated with valsartan: the randomized, open-label, parallel group study VALIDATE. Düsing R, Handrock R, Klebs S, Tousset E, Vrijens B. J Hypertens; 2009 Apr; 27(4):894-901. PubMed ID: 19300114 [Abstract] [Full Text] [Related]
10. Acute effects of high-fat meals enriched with walnuts or olive oil on postprandial endothelial function. Cortés B, Núñez I, Cofán M, Gilabert R, Pérez-Heras A, Casals E, Deulofeu R, Ros E. J Am Coll Cardiol; 2006 Oct 17; 48(8):1666-71. PubMed ID: 17045905 [Abstract] [Full Text] [Related]
11. Effect of antihypertensive treatment with valsartan or atenolol on sexual activity and plasma testosterone in hypertensive men. Fogari R, Preti P, Derosa G, Marasi G, Zoppi A, Rinaldi A, Mugellini A. Eur J Clin Pharmacol; 2002 Jun 17; 58(3):177-80. PubMed ID: 12107602 [Abstract] [Full Text] [Related]
12. Comparison of the effects of valsartan and felodipine on plasma leptin and insulin sensitivity in hypertensive obese patients. Fogari R, Derosa G, Zoppi A, Rinaldi A, Lazzari P, Fogari E, Mugellini A, Preti P. Hypertens Res; 2005 Mar 17; 28(3):209-14. PubMed ID: 16097363 [Abstract] [Full Text] [Related]
13. Effects of valsartan alone versus valsartan/simvastatin combination on ambulatory blood pressure, C-reactive protein, lipoproteins, and monocyte chemoattractant protein-1 in patients with hyperlipidemia and hypertension. Rajagopalan S, Zannad F, Radauceanu A, Glazer R, Jia Y, Prescott MF, Kariisa M, Pitt B. Am J Cardiol; 2007 Jul 15; 100(2):222-6. PubMed ID: 17631074 [Abstract] [Full Text] [Related]
14. Valsartan reduces interleukin-1beta secretion by peripheral blood mononuclear cells in patients with essential hypertension. Li QZ, Deng Q, Li JQ, Yi GH, Zhao SP. Clin Chim Acta; 2005 May 15; 355(1-2):131-6. PubMed ID: 15820487 [Abstract] [Full Text] [Related]
15. Suppressive effects of valsartan on microalbuminuria and CRP in patients with metabolic syndrome (Val-Mets). Shishido T, Konta T, Nishiyama S, Miyashita T, Miyamoto T, Takasaki S, Nitobe J, Watanabe T, Takeishi Y, Kubota I. Clin Exp Hypertens; 2011 May 15; 33(2):117-23. PubMed ID: 21269062 [Abstract] [Full Text] [Related]
16. Hepatic fat content is a determinant of postprandial triglyceride levels in type 2 diabetes mellitus patients with normal fasting triglyceride. Nimitphong H, Phongkitkarun S, Rattarasarn C, Kongsooksai A, Chanprasertyothin S, Bunnag PA, Puavilai G. Metabolism; 2008 May 15; 57(5):644-9. PubMed ID: 18442627 [Abstract] [Full Text] [Related]
17. Association of adiponectin with procollagen type I carboxyterminal propeptide in non-diabetic essential hypertension. Tsai WC, Lin CC, Chen JY, Huang YY, Lee CH, Li WT, Weng CM, Chen JH. Blood Press; 2008 May 15; 17(4):233-8. PubMed ID: 18671144 [Abstract] [Full Text] [Related]
18. Effect of valsartan on monocyte/endothelial cell activation markers and adiponectin in hypertensive patients with type 2 diabetes mellitus. Nomura S, Shouzu A, Omoto S, Nishikawa M, Fukuhara S, Iwasaka T. Thromb Res; 2006 May 15; 117(4):385-92. PubMed ID: 15896827 [Abstract] [Full Text] [Related]
19. [Fasting and postprandial lipids and lipoproteins during the chronic administration of antihypertensive drugs]. Granados V, Ichazo S, Chávez J, Zamora J, Ochoa C, Cardoso G, Posadas C. Arch Inst Cardiol Mex; 1994 May 15; 64(5):469-75. PubMed ID: 7840730 [Abstract] [Full Text] [Related]
20. The plasma levels of soluble P-selectin in subjects with prediabetes. Dogru T, Tasci I, Sonmez A, Genc H, Gok M, Yilmaz MI, Ural AU, Olgun A, Kilic S, Bozoglu E, Erdem G, Erbil K. Int J Clin Pract; 2006 Sep 15; 60(9):1048-52. PubMed ID: 16939545 [Abstract] [Full Text] [Related] Page: [Next] [New Search]